Generic placeholder image

Current Drug Safety

Editor-in-Chief

ISSN (Print): 1574-8863
ISSN (Online): 2212-3911

Case Report

Valproate Induced Acute Pancreatitis - A Unique Case Report

Author(s): Vikramaditya Chauhan, Munish Sharma, Ajita Kapur* and Gulshan Kumar Garg

Volume 17, Issue 4, 2022

Published on: 25 March, 2022

Page: [387 - 389] Pages: 3

DOI: 10.2174/1574886317666220222152355

Price: $65

Abstract

Background: Valproate is a widely prescribed medication for the control of seizures in the pediatric population. It has been reported to be an important implication for drug induced pancreatitis. A case of valproate induced acute pancreatitis operated as surgical abdomen has been reported here.

Case Report: A 13-year-old child presented to the emergency department with severe pain and abdominal distension associated with vomiting and constipation for four days. The patient’s caregivers did not disclose any medication history. Based on clinical examination and ultrasonography that revealed mild free fluid, a provisional diagnosis of pyoperitoneum with peritonitis was made. An emergency exploratory laparotomy was undertaken during which acute pancreatitis was diagnosed intra-operatively. On further enquiry, the caregiver revealed the history of valproate intake for the last six months for generalized tonic-clonic seizures. Valproate was discontinued and there was complete resolution of symptoms.

Conclusion: Both clinicians, as well as caregivers of paediatric patients receiving valproate, should be watchful regarding this possible life-threatening complication to avoid delay in diagnosis and appropriate management.

Keywords: Valproate, acute pancreatitis, drug induced, laparotomy, case report, seizure.

Graphical Abstract

[1]
Pawłowska-Kamieniak A, Krawiec P, Pac-Kożuchowska E. Acute pancreatitis as a complication of antiepileptic treatment: Case series and review of the literature. Pediatr Rep 2021; 13(1): 98-103.
[http://dx.doi.org/10.3390/pediatric13010014] [PMID: 33652736]
[2]
Gerstner T, Büsing D, Bell N, et al. Valproic acid-induced pancreatitis: 16 new cases and a review of the literature. J Gastroenterol 2007; 42(1): 39-48.
[http://dx.doi.org/10.1007/s00535-006-1961-4] [PMID: 17322992]
[3]
Fanta T, Azale T, Assefa D, Getachew M. prevalence and factors associated with perceived stigma among patients with epilepsy in Ethiopia. Psychiatry J 2015; 2015: 627345.
[http://dx.doi.org/10.1155/2015/627345] [PMID: 26425541]
[4]
Yazdani K, Lippmann M, Gala I. Fatal pancreatitis associated with valproic acid: Review of the literature. Medicine (Baltimore) 2002; 81(4): 305-10.
[http://dx.doi.org/10.1097/00005792-200207000-00006] [PMID: 12169885]
[5]
Zaccara G, Franciotta D, Perucca E. Idiosyncratic adverse reactions to antiepileptic drugs. Epilepsia 2007; 48(7): 1223-44.
[http://dx.doi.org/10.1111/j.1528-1167.2007.01041.x] [PMID: 17386054]
[6]
Werlin SL, Fish DL. The spectrum of valproic acid-associated pancreatitis. Pediatrics 2006; 118(4): 1660-3.
[http://dx.doi.org/10.1542/peds.2006-1182] [PMID: 17015559]
[7]
Barbosa SC, Cabrera P, Guerra B, Roman CF. Valproic acid induced necrohemorragic pancreatitis: Case report and diagnostic approach in uncommon pancreatitis. Int J Surg Case Rep 2019; 60: 126-9.
[http://dx.doi.org/10.1016/j.ijscr.2019.05.052] [PMID: 31220680]
[8]
Reis R, Meinardi H. ILAE/WHO “Out of the shadows campaign” stigma: Does the flag identify the cargo? Epilepsy Behav 2002; 3(6S2): 33-7.
[http://dx.doi.org/10.1016/S1525-5050(02)00546-2] [PMID: 12609304]
[9]
The use of the WHO-UMC system for standardised case causality assessment. Available from: https://cdn.who.int/media/docs/default-source/medicines/pharmacovigilance/whocausality-assessmen t.pdf?sfvrsn=5d8130bb_2&download=true (Accessed: 17 June 2022)
[10]
Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30(2): 239-45.
[http://dx.doi.org/10.1038/clpt.1981.154] [PMID: 7249508]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy